SONN
insider transactionsSonnet BioTherapeutics Holdings, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·D
Rao Raghu KEY
Chief Executive Officer
—
22.4K sh
Own -100%
-
Other·D
Chief Business Officer
—
6.4K sh
Own -100%
-
Other·D
Director
—
9.6K sh
Own -100%
-
Other·D
Director
—
10.5K sh
Own -100%
-
Other·D
Chief Financial Officer
—
10.4K sh
Own -100%
-
Other·D
Director
—
4.5K sh
Own -100%
-
Other·D
Director
—
4.4K sh
Own -100%
-
Other·D
Director
—
14.1K sh
Own -100%
-
Other·D
Chief Medical Officer
—
320.0K sh
Own -100%
-
Exercise·M
Chief Medical Officer
—
200 sh
Own New
-
Exercise·M
Chief Medical Officer
—
86.5K sh
Own New
-
Exercise·M
Chief Medical Officer
—
86.5K sh
Own New
-
Other·D
Chief Medical Officer
—
9.4K sh
Own -100%
-
Other·F
Chief Medical Officer
—
16.9K sh
Own -20%
-
Other·D
Chief Medical Officer
—
163.8K sh
Own -100%
-
Exercise·M
Chief Medical Officer
—
163.8K sh
Own New
-
Other·D
Chief Medical Officer
—
69.6K sh
Own -100%
-
Grant·A
Chief Medical Officer
—
200 sh
Own New
-
Grant·A
Chief Medical Officer
—
320.0K sh
Own New
-
Grant·A
Chief Medical Officer
—
8.0K sh
Own +582%
-
Grant·A
Director
—
4.0K sh
Own +1015%
-
Grant·A
Chief Scientific Officer
—
12.0K sh
Own +567%
-
Grant·A
Director
—
10.0K sh
Own +1828%
-
Grant·A
Chief Business Officer
—
6.0K sh
Own +1345%
-
Grant·A
Chief Financial Officer
—
10.0K sh
Own +2667%
-
Grant·A
Rao Raghu KEY
Interim CEO
—
20.0K sh
Own +849%
-
Grant·A
Chief Technical Officer
—
8.0K sh
Own +487%
-
Grant·A
Chief Medical Officer
—
86.5K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Dec 2, 2025 | Rao Raghu KEY | Other D | 22.4K | — |
| Dec 2, 2025 | MCANDREW STEPHEN J | Other D | 6.4K | — |
| Dec 2, 2025 | Dexter Susan | Other D | 9.6K | — |
| Dec 2, 2025 | Bhatt Nailesh | Other D | 10.5K | — |
| Dec 2, 2025 | Griffith Donald J. KEY | Other D | 10.4K | — |
| Dec 2, 2025 | Dyrness Albert D. | Other D | 4.5K | — |
| Dec 2, 2025 | McNeill Lori | Other D | 4.4K | — |
| Dec 2, 2025 | Cini John K. | Other D | 14.1K | — |
| Dec 2, 2025 | Kenney Richard T | Other D | 320.0K | — |
| Dec 2, 2025 | Kenney Richard T | Exercise M | 200 | — |
| Dec 2, 2025 | Kenney Richard T | Exercise M | 86.5K | — |
| Dec 2, 2025 | Kenney Richard T | Exercise M | 86.5K | — |
| Dec 2, 2025 | Kenney Richard T | Other D | 9.4K | — |
| Dec 2, 2025 | Kenney Richard T | Other F | 16.9K | — |
| Dec 2, 2025 | Kenney Richard T | Other D | 163.8K | — |
| Dec 2, 2025 | Kenney Richard T | Exercise M | 163.8K | — |
| Dec 2, 2025 | Kenney Richard T | Other D | 69.6K | — |
| Jul 14, 2025 | Kenney Richard T | Grant A | 200 | — |
| Jul 14, 2025 | Kenney Richard T | Grant A | 320.0K | — |
| Jul 11, 2025 | Kenney Richard T | Grant A | 8.0K | — |
| Jul 11, 2025 | McNeill Lori | Grant A | 4.0K | — |
| Jul 11, 2025 | Cini John K. | Grant A | 12.0K | — |
| Jul 11, 2025 | Bhatt Nailesh | Grant A | 10.0K | — |
| Jul 11, 2025 | MCANDREW STEPHEN J | Grant A | 6.0K | — |
| Jul 11, 2025 | Griffith Donald J. KEY | Grant A | 10.0K | — |
| Jul 11, 2025 | Rao Raghu KEY | Grant A | 20.0K | — |
| Jul 11, 2025 | Dexter Susan | Grant A | 8.0K | — |
| Jun 30, 2025 | Kenney Richard T | Grant A | 86.5K | — |
About SONN insider trading
This page tracks insider transactions for Sonnet BioTherapeutics Holdings, Inc. (SONN) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.